NEWS FEED ~ RECENT ADVANCEMENTS IN AGING RESEARCH
September 20, 2022
A pro‑oxidant combination of resveratrol and copper down‑regulates multiple biological hallmarks of ageing and neurodegeneration in mice
[2022] A pro‑oxidant combination of resveratrol and copper down‑regulates multiple biological hallmarks of ageing and neurodegeneration in mice
[2017] Cell-free chromatin from dying cancer cells integrate into genomes of bystander healthy cells to induce DNA damage and inflammation
Click [√] to See “Young Blood for Old Brains Seminar”
December 12, 2022
Tony Wyss-Coray | Young Blood for Old Brains
In this seminar presented via the Foresight Institute, Tony provides a very good overview of the proteomes impact on and control of aging and by extension the potential therapeutic interventions that will allow for the amerolation of diseases associated with cognitive impairment.
May 10, 2022
New intranasal and injectable gene therapy for healthy life extension
41% Increase in Lifespan
Increase in mouse lifespan by delivering follistatin genes via a CMV vector intranasally.
Using CMV as a gene therapy vector we illustrated that CMV can be used therapeutically as a monthly inhaled or intraperitoneally delivered treatment for aging-associated decline. Exogenous telomerase reverse transcriptase or follistatin genes were safely and effectively delivered in a murine model.
This treatment significantly improved biomarkers associated with healthy aging, and the mouse lifespan was increased up to 41% without an increased risk of cancer. The impact of this research on an aging population cannot be understated as the global aging-related noncommunicable disease burden quickly rises.
May 10, 2022
New intranasal and injectable gene therapy for healthy life extension
41% Increase in Lifespan
Increase in mouse lifespan by delivering follistatin genes via a CMV vector intranasally.
Using CMV as a gene therapy vector we illustrated that CMV can be used therapeutically as a monthly inhaled or intraperitoneally delivered treatment for aging-associated decline. Exogenous telomerase reverse transcriptase or follistatin genes were safely and effectively delivered in a murine model.
This treatment significantly improved biomarkers associated with healthy aging, and the mouse lifespan was increased up to 41% without an increased risk of cancer. The impact of this research on an aging population cannot be understated as the global aging-related noncommunicable disease burden quickly rises.
May 10, 2022
New intranasal and injectable gene therapy for healthy life extension
41% Increase in Lifespan
Increase in mouse lifespan by delivering follistatin genes via a CMV vector intranasally.
Using CMV as a gene therapy vector we illustrated that CMV can be used therapeutically as a monthly inhaled or intraperitoneally delivered treatment for aging-associated decline. Exogenous telomerase reverse transcriptase or follistatin genes were safely and effectively delivered in a murine model.
This treatment significantly improved biomarkers associated with healthy aging, and the mouse lifespan was increased up to 41% without an increased risk of cancer. The impact of this research on an aging population cannot be understated as the global aging-related noncommunicable disease burden quickly rises.
May 10, 2022
New intranasal and injectable gene therapy for healthy life extension
41% Increase in Lifespan
Increase in mouse lifespan by delivering follistatin genes via a CMV vector intranasally.
Using CMV as a gene therapy vector we illustrated that CMV can be used therapeutically as a monthly inhaled or intraperitoneally delivered treatment for aging-associated decline. Exogenous telomerase reverse transcriptase or follistatin genes were safely and effectively delivered in a murine model.
This treatment significantly improved biomarkers associated with healthy aging, and the mouse lifespan was increased up to 41% without an increased risk of cancer. The impact of this research on an aging population cannot be understated as the global aging-related noncommunicable disease burden quickly rises.